← Back to Search

Compassion Meditation for PTSD

N/A
Recruiting
Research Sponsored by Veterans Medical Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary complaint of Posttraumatic Stress Disorder (PTSD) or subsyndromal PTSD with accompanying distress and impairment
Be older than 18 years old
Must not have
Cognitive impairment that would interfere with study activities
Untreated/unstable serious mental illness
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether compassion meditation can help veterans with PTSD.

Who is the study for?
This trial is for Veterans who can consent and have PTSD or similar symptoms causing distress. They must not be in another PTSD treatment or meditation practice, have untreated serious mental illness, cognitive issues that affect participation, untreated substance problems, or severe suicidal/homicidal thoughts.
What is being tested?
The study tests Compassion Meditation (CM) against Applied Relaxation to see if CM helps Veterans with PTSD recover better. It's a test run to see if the methods work well across different locations and how best to measure their effects.
What are the potential side effects?
While specific side effects are not listed for these interventions, relaxation techniques may sometimes lead to increased anxiety or emotional discomfort initially as individuals confront stressful experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am experiencing PTSD or symptoms of PTSD that affect my daily life.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My thinking or memory problems do not interfere with daily activities.
Select...
I do not have an untreated or unstable serious mental illness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Credibility
Enrolment rate
Initiation rate
+4 more
Secondary study objectives
Therapist adequacy addressing treatment elements
Therapist fidelity to intervention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Compassion meditationExperimental Treatment1 Intervention
Compassion meditation is a contemplative meditation practice that fosters compassion through contemplation of common humanity.
Group II: Applied relaxationActive Control1 Intervention
Veteran.calm is an applied relaxation program that exposes participants to a variety of relaxation strategies and their application.

Find a Location

Who is running the clinical trial?

Veterans Health Research Institute of CNYUNKNOWN
Institute for Medical Research, Inc.Industry Sponsor
1 Previous Clinical Trials
120 Total Patients Enrolled
Emory UniversityOTHER
1,708 Previous Clinical Trials
2,607,354 Total Patients Enrolled
Bedford Research Corporation, Inc.OTHER
3 Previous Clinical Trials
1,451 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
867 Previous Clinical Trials
674,827 Total Patients Enrolled
Veterans Medical Research FoundationLead Sponsor
44 Previous Clinical Trials
4,873 Total Patients Enrolled

Media Library

Applied relaxation Clinical Trial Eligibility Overview. Trial Name: NCT04793698 — N/A
Post-Traumatic Stress Disorder Research Study Groups: Applied relaxation, Compassion meditation
Post-Traumatic Stress Disorder Clinical Trial 2023: Applied relaxation Highlights & Side Effects. Trial Name: NCT04793698 — N/A
Applied relaxation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04793698 — N/A
Post-Traumatic Stress Disorder Patient Testimony for trial: Trial Name: NCT04793698 — N/A
~18 spots leftby Jun 2025